2183 ⎘
Genetically modified animals; Animals comprising random inserted nucleic acids (transgenic) inducing loss of function due to mutation of coding region of the transgene (dominant negative)
COMPOSITIONS AND METHODS FOR THE TREATMENT OF LEUKODYSTROPHY AND WHOLE ANIMAL AND CELLULAR MODELS FOR IDENTIFYING EFFICACIOUS AGENTS FOR TREATMENT OF THE SAME
#2HUMANIZED IMMUNODEFICIENT MOUSE MODELS
#3HIGH-WEIGHT BLACK SOLDIER FLY LARVAE, METHODS OF PRODUCING SAME AND USE THEREOF
#4GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE TREM2 P.R47H AND METHODS OF USE THEREOF
#5IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE
#6IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE
#7GENETICALLY MODIFIED RAT MODELS FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID)
#8A HIGH-THROUGHPUT SCREENING METHOD TO DISCOVER OPTIMAL GRNA PAIRS FOR CRISPR-MEDIATED EXON DELETION
#9MODEL ORGANISMS HUMANIZED FOR DRUG DISCOVERY AND SCREENING
#10ENGINEERED CELLS, ANIMAL MODELS, AND USES THEREOF FOR MODELING LOW GRADE GLIOMA (LGG)
#11METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION
#12METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION
#13COMPOSITIONS AND METHODS FOR THE TREATMENT OF LEUKODYSTROPHY AND WHOLE ANIMAL AND CELLULAR MODELS FOR IDENTIFYING EFFICACIOUS AGENTS FOR TREATMENT OF THE SAME
#14COMPOSITIONS AND METHODS FOR CHARACTERIZING A MICROBIOME
#15Genetically modified rat models for severe combined immunodeficiency (SCID)
#16Genetically modified rat models for severe combined immunodeficiency (SCID)
#17ATOPIC DERMATITIS MODEL NON-HUMAN ANIMAL AND USE THEREOF
#18METHOD FOR PREPARING ALZHEIMER'S DISEASE (AD) ANIMAL MODEL
#19loss of function rodent model
#20Compositions and methods for characterizing a microbiome
#21ADAM6 KNOCKIN MICE
#22Mutations in rhodopsin gene in zebrafish and uses thereof
#23Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy
#24Recombinant adenovirus-based interferon biotherapeutics in swine
#25Method of preparing ddx27-deletion zebrafish mutants
#26Genetically modified mouse expressing human APOE4 and mouse Trem2 p.R47H and methods of use thereof
#27Parkinson's disease model and methods
#28Application of GPR45 gene
#29METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION
#30CANINE GENOME EDITING
#31Atopic dermatitis model non-human animal and use thereof
#32Methods and compositions for modulating gene expression
#33Mutations in rhodopsin gene in zebrafish and uses thereof
#34Genetically modified rat models for severe combined immunodeficiency (SCID)
#35Therapeutic agent for sarcopenia and metabolic diseases
#36Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44
#37Methods and compositions for modulating gene expression
#38IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE
#39Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy
#40Parkinsons disease model and methods
#41Transgenic pig models of cystic fibrosis
#42TRANSGENIC PIGS LACKING ONE OR MORE CELLULAR TRANSPORT GENES
#43SorCS1 for the treatment of obesity
#44Genetically modified non-human animals and methods relating to innate immune system response detection
#45GENETICALLY MODIFIED RAT MODELS FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID)
#46Screen and use of therapeutics for pancreatic ductal adenocarcinoma
#47Method for treating arthritis using IK factor or nucleic acid encoding IK factor
#48SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
#49HUMANIZED TRANSGENIC SINGLE NUCLEOTIDE POLYMORPHISM ANIMAL SYSTEMS
#50Animal models of neurological disorders
#51Genetically modified non-human animals and methods relating to innate immune system response detection
#52RbAp48 transgenic mice for drug discovery in age-related memory decline
#53Transgenic pig models of cystic fibrosis
#54Genetically engineered mouse model for autism spectrum disorder having deletion of gene and use thereof
#55TRANSGENIC RODENT EXPRESSING TRUNCATED DISC1
#56Transgenic pig in which HO-1 and TNFR1-Fc are simultaneously expressed, and method for producing same
#57SorCS1 for the treatment of obesity
#58Animal models of neurological disorders
#59Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
#60Transgenic pig model of cystic fibrosis
#61Genetically modified rat models for severe combined immunodeficiency (SCID)
#62SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
#63Erk1/2 posphorylation site specific antibody
#64Targeting TGF-β as a therapy for Alzheimer's disease
#65Ultra-small RNAs as toll-like receptor-3 antagonists
#66NON-HUMAN MAMMAL MODEL OF EPILEPSY
#67METHODS OF MODULATING THE ORGANIC SOLUTE AND STEROID TRANSPORTER (OSTalpha-OSTbeta) ACTIVITY AND TREATING ASSOCIATED CONDITIONS
#68G protein-related kinase mutants in essential hypertension
#69METHODS, COMPOSITIONS AND TRANSGENIC MODELS RELATED TO THE INTERACTION OF T-CADHERIN AND ADIPONECTIN
#70Transgenic pig model for a hereditary neurodegenerative autosomal dominant disease
#71Transgenic porcine models of cystic fibrosis
#72Method of identifying compounds using a transgenic pig model of cystic fibrosis
#73Transgenic pig with altered incretin function
#74Use of agonists and antagonists of IL-23 in the treatment of viral infection
#75G protein-related kinase mutants in essential hypertension